in_the_news_bannerNews & Events Banner

The Latest at Piramal Critical Care

Discover the latest updates, news, and perspectives, highlighting how we are advancing care for patients around the world.

Press Release

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Press Release

February 6, 2026

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas

BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK
Press Release

March 20, 2025

BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK

Piramal Critical Care appoints Jeffrey Hampton as President and Chief Operating Officer
Press Release

June 9, 2023

Piramal Critical Care appoints Jeffrey Hampton as President and Chief Operating Officer

Piramal Critical Care (PCC) commits to reduce its environmental footprint and growing responsibly through sustainable operations
Press Release

November 17, 2022

Piramal Critical Care (PCC) commits to reduce its environmental footprint and growing responsibly through sustainable operations

Piramal Critical Care Launches First to Market, Generic Zinc Sulfate Injection in the U.S.
Press Release

August 18, 2022

Piramal Critical Care Launches First to Market, Generic Zinc Sulfate Injection in the U.S.

Piramal Pharma and Navin Fluorine Mutually Agree on Piramal Increasing its Stake to 100% in Convergence  Chemicals
Press Release

October 28, 2020

Piramal Pharma and Navin Fluorine Mutually Agree on Piramal Increasing its Stake to 100% in Convergence Chemicals

Piramal Critical Care Announces the U.S. Launch of MITIGO™
Press Release

March 11, 2019

Piramal Critical Care Announces the U.S. Launch of MITIGO™

Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from  Mallinckrodt LLC.
Press Release

March 20, 2017

Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.

Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from   Mallinckrodt LLC
Press Release

January 30, 2017

Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC